Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination-Reference-Cited by-同舟云学术

Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination

Published:2016-07 Issue:34 Volume:34 Page:3961-3966
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kemmeren Jeanet,Honsbeek Maaike,Dijkstra Frederika,de Lange Marit,van der Maas Nicoline,Smallenburg Ronald,Koppeschaar Carl,van der Hoek Wim

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. European Medicines Agency. Pandemic Influenza A(H1N1)v vaccines authorised via the core dossier procedure. Explanatory note on scientific considerations regarding the licensing of pandemic A(H1N1)v vaccines. EMEA/608259/2009 rev. [accessed 18.03.11].

2. European Medicines Agency. Committee for Human Medicinal Products (CHMP) Assessment report for Focetria. EMEA/CHMP/503605/2009. [accessed 18.03.11].

3. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/.

4. https://web.archive.org/web/20091031103005/http://www.gsk.com:80/media/pressreleases/2009/2009_pressrelease_10111.htm.

5. Vaccination against the Mexican flu;The Health Council of the Netherlands,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study;Vaccine;2022-07

2. Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe;JMIR Public Health and Surveillance;2017-09-19

3. Forum;Pharmaceutical Medicine;2016-08-25

4. Adverse event collection by questionnaires;Reactions Weekly;2016-07